Back to 
Vident Advisory, LLC
Vident Advisory, LLC
AMLX
4 quarters
Position history for Vident Advisory, LLC's holdings in Amylyx Pharmaceuticals, Inc.
No. Vident Advisory exited its AMLX (Amylyx Pharmaceuticals) position in Q1 2025. Its Q4 2024 13F listed 10,862 shares worth $41,057. Vident Advisory first reported AMLX in Q2 2024 and held it in 3 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$20,603
Total Shares Change
-10,843
Quarter-by-Quarter History
Other major holders of AMLX: FMR LLC, Viking Global Investors LP